| abstract |
A pharmaceutical composition for topical administration for prophylaxis and/or treatment of herpesvirus infections comprising a combination of 0.1-7% (w/w) of a topically acceptable antiviral substance and 0.005-3% (w/w) of an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier, wherein the antiviral substance is selected from the group consisting of acyclovir, cidofovir, desciclovir, famciclovir, ganciclovir, lobucavir, penciclovir, 9-(2-phosphonylmethoxyethyl)adenine, valacyclovir, 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, phosphonoacetate, phosphonoformate, and 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, and salts, esters and other derivatives thereof, whenever applicable. |